Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sander J Robins

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Archives of Internal Medicine|February 11, 2009
Contemporary trends in dyslipidemia in the Framingham Heart StudyErik Ingelsson, Joseph M Massaro, Patrice Sutherland, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 27, 2005
Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention TrialBela F Asztalos, Dorothea Collins, L Adrienne Cupples, et al.
Atherosclerosis|April 22, 2015
Red blood cell fatty acids and biomarkers of inflammation: a cross-sectional study in a community-based cohortJoão D Fontes, Faisal Rahman, Sean Lacey, et al.
Circulation|March 15, 2006
Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention TrialJames D Otvos, Dorothea Collins, David S Freedman, et al.
Obesity (Silver Spring, Md.)|December 25, 2010
Association of subcutaneous and visceral adiposity with albuminuria: the Framingham Heart StudyMeredith C Foster, Shih-Jen Hwang, Joseph M Massaro, et al.
Atherosclerosis|October 14, 2005
The L162V polymorphism at the peroxisome proliferator activated receptor alpha locus modulates the risk of cardiovascular events associated with insulin resistance and diabetes mellitus: the Veterans Affairs HDL Intervention Trial (VA-HIT)E Shyong Tai, Dorothea Collins, Sander J Robins, et al.
Archives of Internal Medicine|December 3, 2002
Diabetes, plasma insulin, and cardiovascular disease: subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT)Hanna Bloomfield Rubins, Sander J Robins, Dorothea Collins, et al.
The American Journal of Medicine|December 31, 2008
Long-term C-reactive protein variability and prediction of metabolic riskTing-hsu Chen, Philimon Gona, Patrice A Sutherland, et al.
Journal of Lipid Research|September 22, 2010
Common genetic variation in multiple metabolic pathways influences susceptibility to low HDL-cholesterol and coronary heart diseaseGina M Peloso, Serkalem Demissie, Dorothea Collins, et al.
Atherosclerosis|November 22, 2005
LpA-I, LpA-I:A-II HDL and CHD-risk: The Framingham Offspring Study and the Veterans Affairs HDL Intervention TrialBela F Asztalos, Serkalem Demissie, L Adrienne Cupples, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Archives of Internal Medicine|February 11, 2009
Contemporary trends in dyslipidemia in the Framingham Heart StudyErik Ingelsson, Joseph M Massaro, Patrice Sutherland, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 27, 2005
Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention TrialBela F Asztalos, Dorothea Collins, L Adrienne Cupples, et al.
Atherosclerosis|April 22, 2015
Red blood cell fatty acids and biomarkers of inflammation: a cross-sectional study in a community-based cohortJoão D Fontes, Faisal Rahman, Sean Lacey, et al.
Circulation|March 15, 2006
Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention TrialJames D Otvos, Dorothea Collins, David S Freedman, et al.
Obesity (Silver Spring, Md.)|December 25, 2010
Association of subcutaneous and visceral adiposity with albuminuria: the Framingham Heart StudyMeredith C Foster, Shih-Jen Hwang, Joseph M Massaro, et al.
Atherosclerosis|October 14, 2005
The L162V polymorphism at the peroxisome proliferator activated receptor alpha locus modulates the risk of cardiovascular events associated with insulin resistance and diabetes mellitus: the Veterans Affairs HDL Intervention Trial (VA-HIT)E Shyong Tai, Dorothea Collins, Sander J Robins, et al.
Archives of Internal Medicine|December 3, 2002
Diabetes, plasma insulin, and cardiovascular disease: subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT)Hanna Bloomfield Rubins, Sander J Robins, Dorothea Collins, et al.
The American Journal of Medicine|December 31, 2008
Long-term C-reactive protein variability and prediction of metabolic riskTing-hsu Chen, Philimon Gona, Patrice A Sutherland, et al.
Journal of Lipid Research|September 22, 2010
Common genetic variation in multiple metabolic pathways influences susceptibility to low HDL-cholesterol and coronary heart diseaseGina M Peloso, Serkalem Demissie, Dorothea Collins, et al.
Atherosclerosis|November 22, 2005
LpA-I, LpA-I:A-II HDL and CHD-risk: The Framingham Offspring Study and the Veterans Affairs HDL Intervention TrialBela F Asztalos, Serkalem Demissie, L Adrienne Cupples, et al.
Pageof 5